amaryl 3 mg tabletti
sanofi oy - glimepiride - tabletti - 3 mg - glimepiridi
tavanic 5 mg/ml infuusioneste, liuos
sanofi oy - levofloxacini hemihydricum - infuusioneste, liuos - 5 mg/ml - levofloksasiini
cardace 10 mg tabletti
sanofi oy - ramipril - tabletti - 10 mg - ramipriili
repevax injektioneste, suspensio, esitäytetty ruisku
sanofi pasteur europe - poliovirus type 1, inactivated, poliovirus type 2, inactivated, poliovirus type 3, inactivated, bordetella pertussis toxoid, adsorbed, bordetella pertussis filamentous haemagglutinin, adsorbed, bordetella pertussis pertactin, adsorbed, corynebacterium diphtheriae toxoid, adsorbed, clostridium tetani toxoid, adsorbed, bordetella pertussis fimbriae, adsorbed - injektioneste, suspensio, esitäytetty ruisku - kurkkumätä-
amaryl 4 mg tabletti
sanofi oy - glimepiride - tabletti - 4 mg - glimepiridi
zolmitriptan sanofi-aventis 2.5 mg tabletti, kalvopäällysteinen
sanofi-aventis oy - zolmitriptanum - tabletti, kalvopäällysteinen - 2.5 mg - tsolmitriptaani
zolmitriptan sanofi-aventis 2.5 mg tabletti, suussa hajoava
sanofi-aventis oy - zolmitriptanum - tabletti, suussa hajoava - 2.5 mg - tsolmitriptaani
vaprino 100 mg kapseli, kova
sanofi oy - racecadotrilum - kapseli, kova - 100 mg - rasekadotriili
sarclisa
sanofi winthrop industrie - isatuximab - multiple myeloma - antineoplastiset aineet - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.
supemtek
sanofi pasteur - influenza a virus subtype h1n1 haemagglutinin, recombinant, influenza a virus subtype h3n2 haemagglutinin, recombinant, influenza b virus victoria lineage haemagglutinin, recombinant, influenza b virus yamagata lineage haemagglutinin, recombinant - influenssa, ihminen - rokotteet - supemtek is indicated for active immunization for the prevention of influenza disease in adults. supemtek should be used in accordance with official recommendations.